14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 61 days ( 0 % )
Last Price $0.102 0 %
High/ Low $0.102 - $0.102 0%
Chg 7 Days N/A $0.102 $0.102
Chg 30 Days N/A $0.102 $0.102
Chg 12 mos -94.25 % $1.77 $0.102
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos -48.90 % Width: 193.78 %
Pred. range - 3 mos $0.102 - $0.102 0 % - 0 %
Pred. range - 12 mos N/A - $0.486 -100.00 % - 377.75 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Sell Mar 06, 2023 - 75 days
Long MA avg 12 mos Sell Mar 06, 2023 - 75 days
Short/Long MA avg 12 mos Sell Mar 01, 2023 - 78 days
Pivot Short Buy Jun 20, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About ObsEva SA

ObsEva SA ObsEva SA, a biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for women suffering from reproductive health and pregnancy. It is developing Linzagolix, an oral gonadotropin releasing hormone receptor antagonist that is in Phase III clinical trial for the treatment of pain associated with endometriosis and heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women. The company ... OBSV Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT